WHO collaborative study on the sero-epidemiology of rubella in Caribbean and Middle and South American populations in 1968.
Knowledge of the rubella antibody profiles of female populations of various ages and in various geographical areas is essential for an intelligent and effective administration of rubella vaccine. The investigation reported was undertaken to extend a previous WHO collaborative study to include additional areas of the Americas. As in the other mainland areas included in the earlier study, the presence of rubella haemagglutination-inhibiting antibody was found to be a likely event in over 80% of the females of child-bearing age in Argentina, Brazil, Chile, urban Peru (Lima) and Uruguay. Antibody rates were significantly lower in Jamaica, Panama, rural Peru and Trinidad. These data confirm and extend earlier findings of low levels of rubella immunity in certain island or isolated populations.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000906:Antibodies; D001118:Argentina; D001938:Brazil; D002648:Child; D002675:Child, Preschool; D002677:Chile; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007563:Jamaica; D010176:Panama; D010568:Peru; D011153:Population; D012409:Rubella / Q000276:immunology*; D014300:Trinidad and Tobago; D014583:Uruguay; D014944:World Health Organization
D000906:Antibodies